Cell & Gene Therapy Manufacturing Market to Reach US$63.0bn by 2036Â
2 July 2026.The global cell & gene therapy manufacturing market is valued at US$13.7 billion in 2026
The global cell & gene therapy manufacturing market is valued at US$13.7 billion in 2026
Healthcare moves home as pharma’s commercial model shifts toward patients
Ukraine is reshaping drone warfare, strike systems and defence production
Patient persistence is becoming pharma’s next growth test after launch
Low-cost drones force faster procurement and resilient defence supply chains
Prevention-led pharma growth depends on earlier intervention, access and scale
Submarine delays push allies towards faster, riskier undersea autonomy bets
Healthcare growth is shifting from standard treatments to personalised patient strategies
Undersea intelligence demand rises as seabed security becomes strategically critical
The global Offshore Remotely Operated Vehicle (ROV) market is projected to grow at a CAGR of 8.1% by 2036
AUKUS Pillar 2 moves undersea autonomy closer to practical delivery
The global Undersea Networked Systems Market is projected to grow from US$6.47 billion in 2026.
The global Uncrewed Underwater Vehicles (UUV) Market is projected to grow from US$6.78 billion in 2026.
The global Mothership / Launch & Recovery Support Systems Market is projected to grow from US$2.51 billion in 2026.
The global Seabed / Fixed Undersea Systems Market 2026-2036 is projected to grow from US$8.14 billion in 2026.
The global Uncrewed Surface Vehicles (USV) Market is projected to grow from US$4.27 billion in 2026.
Women’s health trials enter a more evidence-led, higher-value growth phase
AUKUS faces an industrial test as delivery risks intensify
Defence procurement shifts toward proven, integrated and operationally ready technologies
The global Women’s Clinical Trials & CROs Market is projected to grow at a CAGR of 8.5% by 2036